BRIDGEWAY CAPITAL MANAGEMENT, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$273,558
-34.3%
107,700
-51.6%
0.01%
-36.4%
Q4 2022$416,449
+32.2%
222,700
+81.5%
0.01%
+37.5%
Q3 2022$315,000
+32.9%
122,7000.0%0.01%
+60.0%
Q2 2022$237,000
-34.9%
122,7000.0%0.01%
-28.6%
Q1 2022$364,000
-48.6%
122,700
-22.2%
0.01%
-46.2%
Q4 2021$708,000
+48.1%
157,700
+3.9%
0.01%
+18.2%
Q1 2020$478,000
+16.6%
151,800
+49.1%
0.01%
+83.3%
Q4 2019$410,0000.0%101,800
+7.2%
0.01%0.0%
Q3 2019$410,000
+8.2%
95,0000.0%0.01%
+20.0%
Q2 2019$379,00095,0000.01%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders